JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Comprehensive Analysis of a Six-Gene Signature Predicting Survival and Immune Infiltration of Liposarcoma Patients and Deciphering Its Therapeutic Significance

  • 0Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Henan University, Kaifeng 475004, China.
International Journal of Molecular Sciences +

|

July 27, 2024

|

July 27, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

A new six-gene signature predicts distant recurrence-free survival in liposarcoma (LPS) patients. This model aids in assessing LPS prognosis and developing targeted therapeutic strategies for improved patient outcomes.

Area Of Science

  • Oncology
  • Genomics
  • Bioinformatics

Background

  • Liposarcoma (LPS) is a prevalent soft tissue sarcoma with a poor prognosis due to high rates of metastasis and recurrence.
  • Accurate prognosis evaluation is crucial for improving clinical treatment strategies in LPS patients.

Purpose Of The Study

  • To develop a robust risk prediction model for evaluating the prognosis of LPS patients.
  • To identify key genes associated with distant recurrence-free survival (DRFS) in LPS.

Main Methods

  • Differential gene expression analysis of GEO datasets to identify DEGs.
  • Univariate and Lasso Cox regression for DRFS-associated DEGs and signature development.
  • Kaplan-Meier survival, ROC curve, GSEA, and immune infiltration analyses for model validation and mechanism exploration.

Main Results

  • A prognostic six-gene signature was developed to predict DRFS in LPS patients, demonstrating higher precision in aggressive subtypes.
  • A clinical nomogram was established based on the risk model.
  • GSEA revealed enrichment in cell cycle pathways for the high-risk group, and immune cell abundance differed between risk groups.

Conclusions

  • The developed six-gene signature is a valuable tool for LPS risk assessment.
  • The signature correlates with cell cycle pathways and therapeutic targets, offering insights for improved treatment strategies and patient prognosis.

Keywords: